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 FOREWORD 
 
The Trent  Working Group on Acute Purchasing was set up to enable purchasers to share 
research knowledge about the effectiveness and cost-effectiveness of acute service 
interventions and determine collectively their purchasing policy. The Group is facilitated by 
The School of Health and Related Research (ScHARR), part of the Trent Institute for Health 
Services Research, the ScHARR Support Team being led by Professor Ron Akehurst and 
Dr Nick Payne, Consultant Senior Lecturer in Public Health Medicine. 
 
The process employed operates as follows. A list of topics for consideration by the Group is 
recommended by the purchasing authorities in Trent and approved by the Health Authority 
and Trust Chief Executives (HATCH) and the Trent Development and Evaluation Committee 
(DEC). A public health consultant from a purchasing authority leads on each topic assisted 
by a support team from ScHARR, which provides help including literature searching, health 
economics and modelling. A seminar is led by the public health consultant on the particular 
intervention where purchasers and provider clinicians consider research evidence and agree 
provisional recommendations on purchasing policy. The guidance emanating from the 
seminars is reflected in this series of Guidance Notes which have been reviewed by the 
Trent DEC, chaired by Professor Sir David Hull. 
 
In order to share this work on reviewing the effectiveness and cost-effectiveness of clinical 
interventions, The Trent Institute's Working Group on Acute Purchasing has joined a wider 
collaboration, InterDEC, with units in other regions. These are: The Wessex Institute for 
Health Research and Development, The Scottish Health Purchasing Information Centre 
(SHPIC) and The University of Birmingham Department of Public Health and Epidemiology. 
 
 
 
 
 
 
 
Professor R L Akehurst, 
Chairman, Trent Working Group on Acute Purchasing. 
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 1 
EXECUTIVE SUMMARY 
 
This report explores the use of fluoridated school milk as an intervention to reduce dental 
caries in young children. Health authorities are charged with examining the milk provision to 
young children and disease levels in their districts. The paper reviews the evidence of 
effectiveness, and the situations in the Trent Region where it may be effective as a short 
and/or long-term measure. 
 
A model of the costs and benefits associated with milk fluoridation is presented, including 
the potential for NHS cost savings from a reduced need for treatment. A wide range of costs 
and benefits and, therefore, cost-effectiveness ratios is presented from a societal and an 
NHS perspective. In respect of costs, the influence of different initial disease levels, and of 
different forecasts of the DMFT (decayed, missing and filled permanent teeth) benefits after 
fluoridated milk has ceased to be administered, though not insignificant, are shown to be 
relatively small. 
 
It is demonstrated that milk fluoridation can be as cost-effective as water fluoridation,  
although the magnitude of the absolute benefits will not be as great as from fluoridating 
community water supplies. School milk fluoridation can result in net savings to the NHS 
under some of the scenarios examined, although savings are not redistributed to health 
authorities. A central scenario shows a range of costs per decayed missing and filled 
deciduous teeth (dmft)/DMFT year saved from £0.47 to £26. The range is dependent upon 
the initial caries level in the community and, significantly, on how much of the non-
subsidised cost the health authority is required to take from the Local Authority.  
 
Water is likely to remain the first choice method of fluoridation where it is technically 
possible, economic, and politically acceptable to fluoridate water supplies. The economic 
analysis presented in this paper demonstrates that milk provides a relatively cost-effective 
vehicle for fluoride in the prevention of dental caries. As such, milk fluoridation would appear 
to have a role in the reduction of dental caries. The role will vary by district. The authors are 
committed to producing a ready-reckoner spreadsheet to enable health authorities to model 
cost and benefit implications for their own circumstances. 
 2 
1. INTRODUCTION  
 
This report examines the feasibility of using fluoridated milk in a community programme to 
prevent dental caries in young children in the Trent Region. Although not a new idea 
worldwide, it has only recently been introduced in the UK as a community preventative 
measure in Merseyside and Cheshire amongst infant and junior school children. Average 
disease levels in the Trent Region are not as high as in the North-West Region, but 
individual parts of the Trent Region approach them. The report examines the costs and 
benefits possible with a programme of fluoridated milk, and the situations and disease levels 
where such a programme may be of benefit. The Oral Health Strategy for England
1
 includes 
targets for disease reduction in five year old children, and milk fluoridation may be one of 
the options available to health authorities to achieve progress towards those targets. 
 
1.1 Background and Pathology  
 
Dental caries is the most common disease of late 20th century mankind, affecting virtually 
everyone at some stage in their lifetime. It is most common in young children, particularly in 
deciduous teeth, but can recur at the end of life when gingival recession and reduced saliva 
flow permit root-surface caries. Although deciduous teeth will eventually be lost, their healthy 
presence is essential for the satisfactory development of the permanent teeth and the jaws. 
 
The cause of dental caries is the dissolving of tooth enamel by acids produced as the result 
of fermentation of carbohydrates by oral bacteria present in dental plaque. One of the most 
effective agents in the prevention of dental caries has been the element ‘fluorine’, in the 
form of its ion, ‘fluoride’. 
 
The mechanism for the strengthening of tooth enamel against acid solubility appears to be 
the conversion at the enamel surface of the crystalline hydroxyapatite into the less acid-
soluble hydroxyfluorapatite. In addition, fluoride hastens the remineralisation of incipient 
enamel lesions, and is believed to interfere with glycolysis in which bacteria metabolise 
sugars to produce acid. 
 
Fluoride is at its most effective when present in the drinking water at a concentration in 
excess of one part per million (ppm). This ensures that the teeth are constantly exposed to 
fluoride at an effective concentration. At concentrations in the drinking water greater than 
one ppm there is an increased risk of dental fluorosis. Hence artificial water fluoridation 
programmes are designed to deliver this concentration. 
 
Whilst water fluoridation is the most successful and usually the most cost-effective method 
of preventing dental caries, for various political and practical reasons only 11% of the 
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population of the UK benefit from it. Milk fluoridation may be a satisfactory alternative to it in 
areas where water fluoridation is unlikely to be possible, or not yet achievable. An important 
advantage of fluoridating milk compared with water is that a scheme can be up and running 
in a period of months rather than years. The time between the decision to fluoridate water to 
implementation of a scheme is about five years. Also, because of the way the water supply 
infrastructure transports water around the UK grid, the ability to supply fluoridated water is 
dependent on gaining the approval of all the relevant bodies within a given supply area.  
 
1.2 Prevalence  
 
Dental caries is a cumulative and progressive disease. Its extent in a given population can 
be measured simply by reference to the proportion of the population experiencing the 
disease at that point in time. A better and more widely used indicator of the severity of the 
disease in a given population is called the decayed, missing, and filled teeth index (dmft in 
lower case to distinguish deciduous teeth) or the Decayed, Missing and Filled Teeth Index 
(DMFT in upper case for permanent teeth).
2
  These indices measure the average number of 
decayed missing and filled teeth per person in the population at a given point in time. They 
also give a measure of historical exposure to the disease via the M and F components. 
Avoided increases (relative reductions) in the dmft or DMFT indices are used as measures 
of success in preventing disease. 
 
The wide variation in the point prevalence of dental disease in five year old children in the 
school year 1993/94 in the Trent Region is demonstrated in the following chart: 
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Figure 1  Dental Health of 5 Year Old Children in Trent Region 1993/94 
 
 
  Data not available for Leicestershire 
 
The first main feature of this chart is the size of the inequalities between the South Yorkshire 
districts and Nottingham, and the remaining districts. This is due to the absence of fluoride 
at any effective concentration (usually <0.1 ppm) in South Yorkshire and Nottingham. All the 
other districts in the table have areas of water fluoridation, or natural fluoride, present. 
 
The second main feature is the burden of untreated disease in five year old children 
compared with the lesser amount of active treatment demonstrated. 
 
Similar results for 12 year old children can be shown, albeit the proportion of untreated to 
treated disease is considerably lower. 
 
Figure 2  Dental Health of 12 Year Old Children in Trent Region 1996/97 
 
 
 Data not available for Lincolnshire 
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The proportion of the population at five years of age showing evidence of the disease (the 
cruder measure of prevalence) is similarly variable. Any apparent discrepancies between the 
above figures (1 and 2) and table 1 can be explained by the fact that dental caries is not 
uniformly spread throughout the population. There will be pockets of deprived areas where 
the severity of disease in children is high. This may contribute disproportionately to the dmft 
index.  
 
Table 1 Percentage of 5 Year Old Children Exhibiting Dental Caries By District 
  In Trent Region in 1995/96 
 
DISTRICT 5 YEAR OLDS WITH 
DENTAL CARIES 
EXPERIENCE 
Barnsley 47.5 
Doncaster 49.9 
Lincolnshire 28.5 
North Derbyshire 36.1 
North Nottinghamshire 44.6 
Nottingham 37.8 
Rotherham 53.9 
Sheffield 46.8 
South Humber 41.7 
Southern Derbyshire 38.7 
Source:  Public Health Common Data Set 1997. Dept of Health.  
 
1.3 Outline of Current Service and Scale of Problem in a 'Typical’ District - 
 Doncaster. 
 
Doncaster is a suitable district to choose as an example for the following reasons: 
 Differing sources of drinking water, both trunk main and linked bore-hole supply, causing 
complications for water fluoridation; 
 A high average dental caries level in five year old children, which varies considerably 
through the district; 
 The vast majority of the population (99%) drink water with negligible amounts of natural 
fluoride in it (less than 0.1 ppm). 
 
The changes in dmft for five year old children in Doncaster for the years 1985-1997 are 
shown below:- 
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Figure 3  Changes in Dental Health of 5 Year Old Children in Doncaster 1985-1997 
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It can be seen that there has not been much improvement in 12 years, with the level of 
active treatment gradually falling, and extractions being favoured over fillings. This may be 
due to alterations in the payment system to dentists during this period. The average dmft is 
still persistently near two affected teeth per child (out of 20), and shows no sign of reducing 
to the Government's target of one by the year 2003. 
 
In addition, the inequality within the Doncaster district is apparent when disease levels are 
mapped by Local Authority ward. 
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Map 1  Dental Health in Doncaster 5 year old Children in Doncaster 1995/96 by 
  Local Authority Ward. 
 
An additional problem is the water supply to Doncaster. In the event of water fluoridation 
becoming a practical reality in South Yorkshire, only the western half receives water from 
the main Yorkshire grid. The eastern half, including the priority area of Thorne (the area with 
the highest level of dental decay), receives bore-hole water from six linked boreholes. The 
fluoridation of this small supply scheme would be costly and difficult. At present, however, 
Yorkshire Water Authority is totally opposed to the health authority's request for fluoridation 
and will not introduce it unless forced by legislation. 
 
Recent evaluation of oral health promotion outcomes by the Health Education Authority
3
 has 
concluded that the only effective interventions are those which include the provision of 
fluoride in some form. 
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2.  USE OF FLUORIDATED MILK: SUMMARY OF EVIDENCE OF 
 EFFECTIVENESS  
 
A two-fold approach to the literature search was undertaken. Key-word searches (including 
both the two words ‘milk’ and ‘fluoridation’) were undertaken in Medline, Embase, Biological 
Abstracts, HMIC, Science Citation Index and Social Science Citation Index. In addition, 
known key publications on the subject from the World Health Organisation and the Borrow 
Dental Milk Foundation (BDMF) were consulted. Fluoridation is reputed to be one of the 
most researched public health measures of all time. 
 
2.1 Clinical Trials of Effectiveness 
 
(a) Winterthur, Switzerland. Controlled Trial. 
Dr E Ziegler, a Swiss paediatrician first proposed milk fluoridation in 1953, and described an 
initial scheme.
4
 This was followed up by a larger scheme involving 1,300 children (749 test, 
553 controls), reported by Wirz
5
 after six years in 1964 and Ziegler.
6
 Caries reduction after 
six years ranged from 14.8% to 31.5% in deciduous teeth and from 64.2% to 65.2% in 
permanent teeth. The milk contained one ppm fluoride. 
 
(b) Yokohama, Japan. Controlled Trial. 
2-2.5mg sodium fluoride was added to milk or soup served daily with school meals. After 
four years a 36.3% caries reduction was observed in the permanent teeth of the test group 
receiving fluoride compared with the control group receiving none. This test group 
comprised 167 eleven year olds at the start of the trial who consumed the fluoride in milk for 
150-180 days per year. This was reported by Imamura (1959).
7
 
 
(c) USA. Controlled Trial. 
65 children aged 6-9 years at the start of the trial consumed milk containing 3.5 ppm fluoride 
daily at school for three years. The overall caries reduction was 35%, but for the youngest 
children, aged six at the start, there was a 78% difference between test and control groups. 
This was reported by Rusoff et al (1962).
8
 
 
 9 
(d) Scotland. Double-blind Randomly-allocated Controlled Trial. 
This was a trial in Glasgow in an area of high dental caries. Four and a half to five and a half 
year old children received 1.5 mgm fluoride in 200 ml milk, giving a final concentration of 
seven ppm fluoride. In addition, fluoride monitoring was undertaken by urine sampling and 
analysis. After five years, this double-blind randomly-allocated clinical study resulted in a 
31.2% DMFT reduction in permanent tooth caries in the test group compared with the 
control group.
9
 
 
(e) Hungary. Longitudinal Controlled Trial. 
0.4 mg fluoride for kindergarten children and 0.75 mg for primary school children were 
added daily to 200 ml milk or milk-cocoa for children in a Children's Community in Hungary. 
The children were examined after three, five and 10 years of fluoridated milk consumption. 
The greatest difference between test and control children occurred in both seven and 14 
year olds. Those fluoridated longest benefited most. The overall mean caries difference was 
calculated between test and control groups, giving a 36.8% DMFT reduction favouring 
subjects in the fluoridated milk groups.
10,11
   
The results of these trials are summarised in the following tables. 
  
                   Table 2  Clinical and Community Experiences with Fluoridated Milk; Permanent  
  Dentition Comparisons 
 
 
Country 
 
Duration 
(years) 
 
   Changes in 
         DMFT 
 % Caries 
Reduction 
(DMFT) 
Age at 
Start of Trial 
Reference 
  Fl Non-Fl    
 
Japan 
 
5  
 
- 
 
- 
 
36.3 
 
11 yrs 
 
lmamura (1959)
7
 
 
USA 
 
3.5 
 
0-0.34 
 
0-1.70 
 
78
†
 
 
6-9 yrs 
 
Rusoff (1962)
8
 
 
Switzer-
land 
 
6 
 
- 
 
- 
 
65.2 
 
9-44 months 
 
Ziegler et al. 
(1964)
6
 
 
Scotland 
 
5  
 
0-2.14 
 
0-3.11 
 
31.2 
 
4.5-5.5 yrs 
 
Stephen et al. 
(1984)
9
  
 
Hungary 
 
10  
 
0.63 -
3.61 
 
1.16 -
9.11 
 
36.8 
 
2-5 yrs 
 
Gyurkovics 
(1992)
11
 
† First and second bicuspids and second permanent molars. 
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               Table 3  Clinical and Community Experiences with Fluoridated Milk; Deciduous   
 Dentition Comparisons 
 
 
Country 
 
Duration 
(years) 
 
   Changes in 
         DMFT 
 % Caries 
Reduction 
(dmft) 
Age at 
Start of Trial 
 
Reference 
  Fl Non-Fl    
 
Switzer-
land 
 
6 
 
- 
 
- 
 
14.8-31.5 
 
9-44 months 
 
Ziegler (1964)
6
 
 
Scotland 
 
5  
 
4.3-
6.3 
 
4.5- 
6.0 
 
Not 
significant 
 
4.5-5.5 years 
 
Stephen et al. 
(1984)
9
 
 
Hungary 
 
5  
 
1.42-
2.40 
 
1.69-
4.01 
 
40.1  
 
2-5 years 
 
Banoczy et al. 
(1985)
10
 
 
 
2.2 Current UK Trials with Fluoridated Milk 
 
The first UK milk fluoridation scheme commenced in St. Helens, Merseyside in June 1993, 
following a successful feasibility study completed in 1991.
12
 The study conducted by a team 
from the University of Liverpool, headed by Professor M A Lennon, looked at the 
organisational, epidemiological and legal aspects of using milk as a vehicle for fluoride. The 
study showed that 23% of four year old children in St Helens had high caries experience 
(dmft>4). There are currently over 3,000 children between the ages of three and seven in St. 
Helens drinking 189ml school milk to which 0.5 mg of fluoride has been added. This 
concentration is 2.65 ppm, which is the current recommended level.
13
 The scheme has 
provided valuable experience in technical and organisational aspects of milk fluoridation and 
generated interest in other districts investigating the possibility of introducing milk 
fluoridation. In 1996, Wirral Health Authority introduced milk fluoridation and there are now 
over 6,000 children in this scheme. More recently, in 1997, St. Helens & Knowsley Health 
Authority extended the existing scheme in St. Helens to neighbouring Knowsley and a 
scheme was implemented in Winsford, South Cheshire. There are currently over 15,000 
children participating in the UK programme. The University of Liverpool is evaluating the 
dental health gain and is also monitoring urinary fluoride excretion, to ensure that fluoride 
intake from all sources by the children involved is at the appropriate level. In addition, it 
monitors the microbiological quality of school milk (fluoridated and non-fluoridated), and the 
levels of fluoride in the fluoridated milk. Storage temperatures are also recorded at 
distribution depots and schools. Initial results were reported by Lennon et al. in 1995.
14
  The 
pre-trial decay levels of five year olds in the Wirral in 1993 were 2.23 dmft per child. This is 
comparable with the disease levels in South Yorkshire and Nottingham districts at that 
period. 
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2.3 Comparisons with Water Fluoridation 
 
Worldwide studies in excess of 100 since 1945 have shown a reliable reduction of 40-49% 
in dmft levels of in deciduous teeth for lifetime consumption of water fluoridated at one 
ppm.
15
 The comparable benefit for permanent teeth has been in the region of 50-59%, 
where caries levels were high. 
 
Water fluoridation is usually effective for 365 days of the year; however, because of the 
problems of supplying individual children on non-school days, milk fluoridation is undertaken 
at school only. Thus, the effect of the fluoride is reduced as the average school attendance 
is approximately 200 days per year. The benefits of fluoride in school water have been 
demonstrated in the USA.
16
  Horowitz reports that the caries reduction is approximately 30% 
in permanent teeth, which is perhaps predictable from the proportion of 200:365 days 
exposure to school water. Jaso-Margarit et al.
17
 have shown that the bio-availability of 
fluoride incorporated into either milk or water is similar. 
 
2.4 Conclusion on Direction of Evidence and its Quality 
 
The randomised controlled trials using double-blind allocation and examination provide the 
highest level of evidence of effectiveness. The comparatively small scale of the early trials 
may be seen as a disadvantage, but the consistency of the results in five different countries 
weighs against this. The close agreement with the results for water fluoridation (one of the 
most studied public health measures ever), and comparison with the laboratory-derived 
theoretical data, provide evidence of the effectiveness of milk fluoridation in the reduction of 
the level of dental decay in children. Because fluoride in milk would be administered after 
the age of risk from dental fluorosis, the latter is not an issue of concern.  
 
There are, however, certain points which would benefit from further study. These relate to 
the benefit obtained at various levels of dental decay from fluoridated milk, and its role in 
areas where water fluoridation may be a possibility. The evidence shows clearly that its 
effectiveness is not as great as that of water fluoridation, and it should not be promoted as a 
preferred alternative to it. 
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3. COST AND BENEFIT IMPLICATIONS OF ADOPTING INTERVENTION 
 
3.1 Introduction  
 
There are no known papers published in English formally reporting the cost-effectiveness, 
nor indeed the costs, of milk-fluoridation schemes. Few publications make even a passing 
reference to costs
18,19,20,21
 and in papers written in Spanish, Villa
22,23
 argues that milk 
fluoridation can be thousands of times more cost-effective than water fluoridation under 
certain circumstances. Stamm, on the other hand, concluded that using milk as a fluoride 
vehicle could be costly, although the relevance of this analysis to today is limited in that this 
was based on 1955 data for New York City.
24
  The WHO, (which has classified milk as a 
highly cost-efficient vehicle for fluoridation
19
) is co-ordinating a number of clinical trials of 
milk fluoridation throughout Europe and Africa. One of these is the trial in the Wirral already 
referred to in chapter 2. No economic analysis is expected from this trial before the year 
2000. 
 
In view of the lack of published research evidence on the cost-effectiveness of milk 
fluoridation, this paper attempts to estimate the costs and benefits of milk fluoridation using  
a spreadsheet modelling approach. The modelling assumptions are made using evidence of 
benefits from the literature, and local knowledge for consent and costing information, where 
necessary. 
 
3.2  Economic Analysis: Estimation of Health Benefits 
 
The benefits of fluoridation are usually expressed in terms of reduced dmft/DMFT. The 
model uses results presented by Birch
25
 which estimate the dmft/DMFT benefits of water 
fluoridation with necessary adjustments for fluoridation using milk. This study is used in 
preference to milk fluoride research evidence because of the more detailed age-specific 
evidence about dmft and DMFT benefits. Birch reports the health benefits from the age of 4 
to 14, ignoring any benefits of water fluoridation before the age of four years for children 
who have been exposed to fluoridated water from birth. There are no health benefits from 
milk fluoridation before administration of the product at the age of four years. Consequently, 
the results reported by Birch need to be adjusted.  
 13 
Key Model Assumptions:- 
 The model assumes that a high caries area is one where the dmft is 3.3 for five year 
olds, and a low caries area is one where the dmft is 1.0 for the same age group. 
 Fluoridated school milk is administered for four years from the age of four to eight. 
 Milk fluoridation produces the same benefit effect as water but with a pro-rata 
adjustment for the number of days exposure.
16,17
 It is assumed that school milk is 
administered 200 days of the year so that the benefits of milk fluoridation are assumed 
to be those of water multiplied by 0.55, (200/365). 
 
All the above are central scenario assumptions and can be tested using sensitivity analysis. 
 
3.2.1 Modelled Benefits to an Individual 
 
The model reports the estimated reductions in dmft and DMFT, saved dmft and DMFT 
years. It does this for an individual four year old and for the population of children aged 4 to 
14 in a health district of 500,000 total population. 
 
Birch reports the following reductions in dmft/DMFT for water fluoridation for children living 
in high and low caries prevalence areas.
25
 These figures imply a caries reduction of 60% in 
dmft at eight years of age and 54% reduction in DMFT at 14 for a high caries area. The 
equivalent figures for a low caries area are 40% and 34% respectively.  
 
Table 4 Water Fluoridation Reduction in dmft/DMFT by Age and Caries Level 
25
 
 
Caries Age 4 5 6 7 8 9 10 11 12 13 14 
HIGH dmft 1.0 2.0 2.0 3.0 3.0 1.5      
 DMFT     0.5 0.8 1.2 1.5 2.1 2.4 2.7 
 Total 1.0 2.0 2.0 3.0 3.5 2.3 1.2 1.5 2.1 2.4 2.7 
LOW dmft 0.2 0.4 0.6 0.8 0.8 0.4      
 DMFT     0.1 0.2 0.2 0.3 0.5 0.7 0.9 
 Total 0.2 0.4 0.6 0.8 0.9 0.6 0.2 0.3 0.5 0.7 0.9 
 
The effects of removing the benefits of fluoride before four years of age are presented in 
table 5. 
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Table 5 Assumed Water Fluoridation Benefits from Fluoride Introduced at Age 4 
 
Caries age 4 5 6 7 8 9 10 11 12 13 14 
HIGH dmft 0.0   1.0   1.0   2.0   2.0   1.0      
 DMFT     0.5 0.8 1.2 1.5 2.1 2.4 2.7 
 Total 0.0   1.0   1.0   2.0 2.5 1.8 1.2 1.5 2.1 2.4 2.7 
LOW dmft 0.0 0.2 0.4 0.6 0.6 0.3      
 DMFT     0.1 0.2 0.2 0.3 0.5 0.7 0.9 
 Total 0.0 0.2 0.4 0.6 0.7 0.5 0.2 0.3 0.5 0.7 0.9 
 
The reduced days of exposure to fluoride via school milk mean that the central case 
assumes that the reduced dmft/DMFT benefits of milk fluoridation are only 55% of those 
from water fluoridation. Because fluoridated milk is only administered for four years, 
assumptions have to be made about the DMFT benefits of milk fluoridation, once fluoridated 
milk has ceased at the age of eight. The literature provided no evidence about what 
happens to caries prevalence in a given cohort of patients on cessation of fluoridation. The 
papers which did look at cessation of fluoridation examined the effects on different cohorts 
of patients with a given age.
26,27,28
  For example, Attwood
28
 reported a 50% difference in 
caries prevalence present in 10 year olds living in a fluoridated and a non-fluoridated 
community. Three years after cessation of fluoridated water, the difference in caries 
prevalence between 10 year olds in the two communities had fallen to 39%. 
 
For modelling purposes, a pessimistic scenario assumes that the benefits of milk fluoridation 
last only for the four years that the school milk is administered, so that the DMFT reverts to 
that of the non-fluoridated group from nine years of age. An optimistic scenario assumes 
that children aged 8 to 14 gain the 55% of the benefits achieved by that age group in the 
Birch water fluoridation work as given in table 5. A more central assumption is that the 
DMFT benefits reduce linearly from 55% at 8 years of age to 0% at 15. Table 6 shows the 
assumed percentage reductions in DMFT as determined by these three benefit scenarios.  
 
Table 6 Assumed DMFT Reductions under Three Different Benefit Scenarios 
 
 DMFT Reduction at Age 11 
 
DMFT Reduction at Age 14 
 
Scenario Low Caries High Caries Low Caries High Caries 
Pessimistic   0%   0%   0% 0% 
Central   6% 16%   3% 4% 
Optimistic 11% 27% 21% 30% 
 
The table shows the relatively modest benefit assumptions of the central scenario, 
particularly for the 14 year old age group. Teeth are at their greatest risk from caries 
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immediately after eruption.
29
  As such, it could be argued that even the above central 
scenario assumptions err on the side of pessimism. 
 
The central scenario assumptions imply that a four year old from a high caries area 
receiving fluoridated school milk for four years would benefit by 6.5 dmft/DMFT free years 
for the 10 years between the ages of 4 and 14. In a low caries area, the benefit would be 
lower at 1.77 years. Using a discount rate of 6%, the discounted benefits are 5.29 and 1.45 
dmft/DMFT free years respectively. These results, together with the optimistic and 
pessimistic scenario results are presented in table 7. 
 
Table 7 dmft/DMFT Years Saved per Child Treated (in 10 Years following Start 
  of Treatment at Age 4) 
 
 Undiscounted  Discounted (6%)  
Scenario Low Caries High Caries Low Caries High Caries 
Pessimistic 1.21 4.11 1.06 3.62 
Central 1.77 6.50 1.45 5.29 
Optimistic 2.74 9.97 2.06 7.51 
 
The table shows a range of dmft/DMFT years saved per child treated. Depending on the use 
of a discounting rate, the model indicates a range from 3.62 to 9.97 dmft/DMFT years saved 
in a high caries area, to 1.06 to 2.74 dmft/DMFT years saved in a low caries area. 
 
3.2.2 Modelled Benefits to the Community 
 
In order to model the benefits to the community, further assumptions need to be made. 
These include:- 
 The central scenario assumes that 70% of parents give their consent for fluoridated milk 
to be administered to their child. 
 To model the population benefits, the model assumes that the percentage of four year 
olds in a ‘typical’ district is the same as the proportion of four year olds in England and 
Wales. The latter has been estimated using the proportion of 1-4 year olds in England 
and Wales (5.17%)
30
 and dividing by four (1.29%). This figure is re-multiplied by four to 
estimate the number of 4-8 year olds receiving fluoridated milk.a 
 All the benefit scenarios count only the benefits in the 10 year period following the start 
of consumption of fluoridated milk. The number of four year olds in the population has 
                                                          
a  Because we are referring to school years, children’s ages will range from four to eight even though we 
 only consider four school years. 
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been multiplied by 10 to derive an estimate of the number of children in the 4-14 year 
age band. 
 The model is a steady state model in that it assumes a scheme has been up and 
running for at least 10 years. The population benefits will be lower at the start of a 
scheme for the first cohorts of five, six and seven year olds, who would only receive 
three, two and one year of treatment respectively. 
 
The 70% consent figure is based on an overall consent figure of 72% of children in the 
Wirral scheme who receive school milk and have taken up the fluoridated milk option. There 
is considerable variation around this mean figure. For example, the uptake figures using 
negative and positive consent forms are 84% and 61% respectively. Using these central 
scenario assumptions, it is assumed that there are 6,430 four year olds in a health district of 
500,000 total population. Table 8 presents the estimated annual benefits in terms of 
dmft/DMFT years saved to the children aged 4 to 14 from such a health district under steady 
state assumptions. 
 
Table 8 Steady State Modelled dmft/DMFT Years Saved per annum for a Health 
  District of 500,000 population 
 
DMFT Scenario Low Caries High Caries 
Pessimistic 5,426 18,496 
Central 7,962 29,277 
Optimistic 12,331 44,884 
 
The model indicates a range from 18,496 to 44,884 dmft/DMFT years saved per annum in a 
high caries area, to 5,426 to 12,331 dmft/DMFT years saved per annum in a low caries 
area. It will take 10 years of a milk fluoridation scheme to reach these levels of benefit. 
 
3.3 Economic Analysis: Estimation of Net Costs 
 
3.3.1 Introduction 
 
The cost of a school milk fluoridation scheme raises some interesting issues in the context 
of this Guidance Note series. Health economists normally like to include all the societal 
costs of health care interventions when undertaking economic analyses. That is, all the 
direct and indirect opportunity costs irrespective of who pays, whether it be Government, tax 
payers, the NHS, Trusts, health authorities, GPs, patients or their families, friends, carers or 
employers. In this series of Guidance Notes, it is the usual practice to measure only the 
direct costs of interventions to the NHS. The costs to others are usually treated as negative 
benefits.  
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The elements which make up the vast majority of the costs of a fluoridated milk scheme 
include the following: 
 
 The production costs including the cost of fluoride, packaging, and distribution; 
 Distribution to and within the school; 
 General scheme administration costs (e.g. obtaining parental consent). 
 
The production costs for fluoridated school milk are effectively the same as those of non-
fluoridated milk. The costs of adding the fluoride to the milk, packaging, and labeling it are 
so minimal that these marginal costs have been absorbed by the dairies involved in the 
North-West schemes. For example, a dairy not already producing fluoridated milk may 
decide to purchase a tank devoted to the production of fluoridated milk. Such stainless steel 
tanks cost around £5,500 and have a long working life. Assuming a capital life of 30 years, 
and a discount rate of 6%, the annualised cost of such an investment is estimated at £400 
per annum, or £1.09 per day. The tank cost per carton of milk is negligible, therefore.  
 
The purchase price of fluoridated milk is about 11p per 189ml (
1/
3 of a pint) carton. Local 
Authorities are responsible for contracting for the milk with the local dairy. Since the 1986 
Social Security Act, Local Authorities are prevented from providing free school milk to 
primary as well as secondary school children. Local Authorities are responsible for levying a 
parental contribution for the provision of school milk. The amount to be levied can vary by 
Local Authority. 
 
There are two subsidies available for school milk. Both are available for children up to five 
years of age. The European Community (EC) School Milk Subsidy Scheme is provided 
through the Government Intervention Board
31
 and is available to children, whatever their 
age, as long as they are in full time primary education. At September 1998, the subsidy 
levied is 12.42 pence per pint of whole milk (approximately 40% of the cost of the milk 
product). It has to be claimed by the Local Authority on behalf of schools. 
 
The Welfare Food Scheme is operated by the Welfare Food Reimbursement Unit (WFRU)
31
 
and provides free school milk (one third of a pint) up to the fifth birthday for children in full 
time education. It can be claimed by schools on an individual basis, and funds the full cost of 
the milk product minus any EC subsidy claimed by the Local Authority. Under the strictest 
definitions, the addition of fluoride to milk turns milk from being a natural food into a 
processed food and, as such, it may not be eligible for subsidy. However, in practice to date, 
the subsidy has been paid. 
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Unless health authorities decide to contribute to the cost of the product itself, the greatest 
cost to the NHS is the time of staff spent on setting up and monitoring a scheme, for 
example, the printing, distribution, and collation of parental consent forms. This will normally 
be co-ordinated by the Consultant in Dental Public Health, or one of his/her staff. Many of 
the operational costs of a school milk service can fall upon the Community Dental Service 
(CDS), including the promotion of the scheme amongst the schools, dealing with consent 
issues, and gathering uptake data for the health authority. The local Community Trust 
involved in the Wirral Scheme has estimated the staff time commitment at 0.5 of a whole 
time equivalent for a dental worker, implying a cost of about £10,000 per annum. The health 
authority staff resource is considerably less than the Community Trust figure for the Wirral 
scheme. This analysis does not include an estimate of Local Authority staff time. 
   
The health authority may choose to co-ordinate the whole scheme, but the BDMF can have 
a significant role to play. It can provide technical support to the dairies, and can help to plan 
a scheme. It is willing to consider providing assistance in the form of an operational 
consultant for the implementation of a scheme. 
 
Given the distribution of the cost burden of a fluoridated milk scheme, this Guidance Note 
presents costings taken from a societal, an NHS, and a health authority perspective. 
 
3.3.2 Gross Costs 
 
A costing analysis should always attempt to measure marginal opportunity costs. In this 
context it is difficult to identify the margin as it will depend, amongst other things, on the 
current provision of school milk in a ‘typical’ district. The margin, as far as the health service 
is concerned, will also depend upon the level of subsidies available and on how much of the 
cost burden the health authority and the Local Authority are willing to take on between them. 
 
The following analysis presents cost estimates with and without subsidies included, and will 
include the full cost of fluoridated milk. In effect, the analysis is assuming that the NHS is 
taking on the full marginal costs of a fluoridated milk scheme and is, thus, a pessimistic view 
as far as the NHS is concerned. 
 
The current price of a one third pint carton of fluoridated milk is about 11 pence. Assuming 
200 school days per annum, the annual cost is estimated at £22 per child. This cost will be 
subsidised to the full amount for children under the age of five years, and by 12.42 pence 
per pint  for children aged five or over (September 1998 subsidy figure). 
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Assuming, rather pessimistically, that the costs of the health authority staff are half of those 
of the community trust, the annual NHS staff costs are estimated at £15,000. Assuming 
70% consent, a ‘typical’ district could expect 18,003 children aged 4-8 to be on the scheme 
at any one time. Consequently, the staff cost per child per year is about 83 pence only. 
 
Table 9 Four Year Societal Costs of Fluoridated Milk:  
  Cost per Treated Child 
 
Cost Item Year 1 
£ 
Year 2 
£ 
Year 3 
£ 
Year 4 
£ 
Total 
£ 
Average  p.a. 
£ 
Fluoridated Milk Price 22.00  22.00  22.00  22.00  88.00   22.00 
NHS Staff Time   0.83    0.83    0.83    0.83    3.33     0.83 
Total 22.83  22.83  22.83  22.83  91.33   22.83 
Discounted Total  22.83  21.54  20.32  19.17  83.87   20.97 
 
For a ‘typical’ population of 500,000 people with 18,000 children on the scheme at any one 
time, the societal cost is estimated as £377,000 per annum. Table 10 takes a health 
authority costing perspective and assumes that the EC and Government subsidies are 
available. 
 
Table 10 Four Year Discounted NHS Costs of Fluoridated Milk: Cost per Treated 
Child 
 
Cost Item Year 1 
£ 
Year 2 
£ 
Year 3 
£ 
Year 4 
£ 
Total 
£ 
Average £  
p.a. 
Fluoridated  Milk Price 22.00  22.00  22.00  22.00  88.00  22.00 
EC Subsidy   8.28    8.28    8.28    8.28  33.12   8.28 
UK Subsidy   6.86    -     -     -            6.86   1.72 
EX. Subsidised Cost   6.86  13.72  13.72  13.72  48.02  12.01 
NHS Staff Time   0.83    0.83    0.83    0.83    3.33   0.83 
Subsidised Total    7.69  14.55  14.55  14.55  51.35  12.84 
Discounted Total   7.69  £13.73  12.95  12.22  46.59  11.65 
 
The estimated gross subsidised cost to a health authority is £210,000 per annum. These are 
reasonably high cost assumptions in that they assume that the health authorities pick up the 
full marginal cost minus the subsidies. An optimistic health authority costing scenario 
assumes that the cost to the health authority is simply the cost of staff time. That is, £15,000 
per annum, or £0.83 per treated child per annum. 
 
3.3.3 Modelled Treatment Cost Savings 
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In addition to the health benefits of milk fluoridation, there will be some savings to the NHS 
resulting from avoided treatment costs. The following analysis uses the dmft/DMFT saving 
figures which were used to model benefits in the previous sub-section of this paper. It is the 
incidence and not the prevalence of caries which is the relevant concept to measure in this 
context. It is assumed that each incidence of caries is only treated once in the 10 year 
period when a child is aged 4 to 14. Whilst this assumption is reasonable to make in the 
context of extractions, it is a conservative assumption for restorations. Analysis of Trent data 
indicates that only about 25% of caries is treated (by fillings and extraction), the remaining 
75% is untreated tooth decay. It is assumed, therefore, that only 25% of saved dmft/DMFT 
avoids treatment costs in the following analysis.  
 
The cost savings of avoided treatment are then estimated using an assumed cost of £20 per 
treatment
32
 and a financial discount rate of 6%. The actual cost of treatment is clearly 
dependent upon the casemix under consideration in terms of fillings, extractions and the 
type of tooth affected by caries. The £20 estimate includes an estimate of costs to patients 
and their families. This rather high cost assumption counterbalances to some extent the 
conservative once in the ten year treatment assumption used. The estimated net present 
values (NPVs) of the cost savings of avoided treatment for an individual four year old as 
estimated to age 14 are given in table 11. 
 
Table 11 Estimated NPV of Cost Savings per Treated Child 
 
Scenario Low Caries (£) High Caries (£) 
Pessimistic 1.78   6.33 
Central 2.07   7.16 
Optimistic 3.23 10.47 
 
The table shows the estimated cost savings from avoided treatment for an individual to be 
small, especially in an area of low caries prevalence. The annual cost savings from a district 
population perspective and under steady state assumptions are given in Table 12. 
 
Table 12 Annual Cost Savings to NHS for a Health District of 500,000 Population 
 
Scenario Low Caries (£) High Caries (£) 
Pessimistic   8,023 28,482 
Central   9,320 32,227 
Optimistic 14,514 47,137 
 
Both of the above tables indicate that the central scenario cost savings are skewed towards 
the results of the pessimistic scenario. This phenomenon is a result of the fact that the Birch 
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results for water fluoridation show the DMFT index gap widening as time increases. 
Consequently, there is assumed to be new incidence of caries avoided year on year in the 
optimistic scenario. This is not true for the pessimistic scenario, nor for the central scenario 
which, because of the way it is constructed, assumes very little new incidence of avoided 
caries for children aged nine or over. It is important to note that, under present 
arrangements, these savings will be made by the NHS centrally and will not be redistributed 
to purchasing authorities. 
 
3.3.4 Modelled Net Costs 
 
In modelling net cost estimates, three perspectives are presented. The societal perspective, 
the NHS perspective, and the health authority perspective. In the former, the full costs of a 
milk fluoridation scheme (without subsidies) are included along with all estimates of 
treatment savings. Two NHS perspectives are presented. The low cost scenario assumes 
that only NHS staff costs are included in the analysis, together with estimated treatment 
savings. In the high cost scenario, the NHS is assumed to absorb all of the non-subsidised 
costs of a scheme together with the estimated treatment savings. The two health authority 
costing scenarios are the same as the NHS scenarios except that the gross costs are not 
offset by any treatment cost savings, as currently these are kept centrally and are not re-
distributed to the health authorities. 
 
To derive net costs, the NPV of the discounted cost savings (estimated over 10 years) is 
subtracted, when appropriate, from the NPV of the costs incurred over the four years of 
treatment. Table 13 shows the estimated NPVs of the net costs per child treated under the 
three DMFT benefit scenarios. A 6% discounting assumption is used. 
 
Table 13 Estimated NPV of Net Costs Per Treated Child 
 
 Pessimistic  
DMFT Scenario 
Central  
DMFT Scenario 
Optimistic  
DMFT Scenario 
Costing 
Perspective 
Low 
Caries 
£ 
High 
Caries 
£ 
Low 
Caries 
£ 
High 
Caries 
£ 
Low 
Caries 
£ 
High 
Caries 
£ 
Societal 82.08 77.54  81.80  76.71  80.64 73.39 
HA High Cost 46.59 46.59 46.59 46.59 46.59 46.59 
HA Low Cost   3.06   3.06   3.06   3.06   3.06  3.06 
NHS High Cost 44.81 40.27  44.52   39.43  43.37 36.12 
NHS Low Cost   1.28  -3.27   0.99  -4.10  -0.16  -7.41 
 
There is no difference between gross and net costs, if adopting a health authority 
perspective, because they realise no treatment cost savings. Consequently, the health 
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authority cost figures are also independent of any DMFT benefit scenario assumptions. 
Table 14 presents the net cost figures based on a ‘typical’ health authority population of 
500,000 total residents. 
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Table 14 Population-Based NPV Net Costs per Annum 
 
 Pessimistic  
DMFT Scenario 
Central  
DMFT Scenario 
Optimistic  
DMFT Scenario 
Costing 
Perspective 
Low 
Caries 
£ 
High 
Caries 
£ 
Low 
Caries 
£ 
High 
Caries 
£ 
Low 
Caries 
£ 
High 
Caries 
£ 
Societal 369,440 348,981 368,143  345,236 362,947 330,327 
HA High Cost 209,709 209,709 209,709  209,709 209,709 209,709 
HA Low Cost   13,774   13,774   13,774   13,774  13,774   13,774 
NHS High Cost 201,686 181,227  200,388  177,482 195,192 162,572 
NHS Low Cost     5,751  -14,708     4,453  -18,453      -742 -33,363 
 
Tables 13 and 14 illustrate the relatively small impact of the different caries levels and 
benefit assumption compared with the impact of the costing perspective adopted. The 
difference between the high and low cost health authority scenarios is dependent on how 
much of the cost of the milk product the health authorities are willing to bear, or are made to 
bear by Local Authorities. 
 
3.4 Economic Analysis: Estimation of Cost-effectiveness 
 
Possible measures of cost-effectiveness in the current context are the cost per DMFT/dmft 
avoided and the cost per DMFT/dmft free years. The previous two sections have illustrated 
a wide range of estimates of benefits and costs for a milk fluoridation scheme. The range of 
benefits available will depend, amongst other things, on the current prevalence of caries in 
the community and the assumptions made about the effectiveness of milk fluoridation during 
and beyond the administration of the school milk years. The range of cost estimates is 
largely dependent on how the margin is defined and from whose perspective the costing is 
undertaken; Society: the NHS as a whole, or a health authority. This range of cost and 
benefit estimates will combine to give a wide range of estimates of cost-effectiveness. 
 
Table 15 presents the cost per dmft/DMFT year saved where avoided caries years saved 
are undiscounted, but where costs are net costs and are discounted using a 6% discounting 
factor. The ratios are presented using optimistic, central, and pessimistic predictions of 
DMFT benefits for high and low caries areas. The costing scenarios again represent 
societal, NHS, and health authority perspectives. Table 15 demonstrates a wide range of 
cost-effectiveness results. 
 
 24 
Table 15 Cost Per dmft/DMFT Year Saved 
 
 Pessimistic  
DMFT Scenario 
Central  
DMFT Scenario 
Optimistic  
DMFT Scenario 
Costing 
Perspective 
Low 
Caries 
£ 
High 
Caries 
£ 
Low 
Caries 
£ 
High 
Caries 
£ 
Low 
Caries 
£ 
High 
Caries 
£ 
Societal  68.09  18.87  46.24  11.79  29.43  7.36 
HA High Cost  38.31  11.24  26.10  7.10  16.85  4.63 
HA Low Cost    2.54  0.74  1.73  0.47  1.12  0.31 
NHS High Cost  36.83  9.70  24.93  6.00  15.68  3.58 
NHS Low Cost   1.06 net saving  0.56 net saving net saving net saving 
 
From a societal perspective, the estimates vary from £7 to £68 per caries year saved. It 
could be argued that all these societal cost-effectiveness ratios overestimate the true cost -
effectiveness ratios in that the marginal cost is the whole cost of the fluoridated milk, 
whereas the benefits only measure the caries benefits of fluoridated milk. It could be argued 
that, because the economic analysis only measures the caries benefits of fluoridated milk, 
the relevant marginal cost is the cost of the fluoride and the administration costs of a 
fluoridated milk scheme. This would be the case, for example, where a school milk scheme 
was already in place and we were interested in measuring the marginal costs and benefits 
of adding fluoride to the milk. The cost-effectiveness ratios given for the NHS low cost 
scenario in table 15 are more representative of this viewpoint. Four of these six ratios 
indicate a net saving, and the worst case scenario is £1.06 per dmft/DMFT year saved.  
 
The 12 ratios giving the NHS and HA perspectives are similar and only differ because the 
former allows for net cost savings from a reduced need for dental treatment. From a health 
authority perspective, the figures range from 31 pence to £38 per dmft/DMFT year saved 
depending on costing perspective, high versus low caries prevalence, and DMFT forecasted 
benefit scenario. Again, the HA and NHS high cost perspectives are relatively pessimistic in 
that they assume the NHS picks up the full non-subsidised cost of a milk fluoridation 
scheme. The experience in the North-West has been that the NHS has paid only for the 
NHS staff resource in the scheme, so that the HA low cost row of table 15 is the most 
relevant set of cost-effectiveness ratios for the North-West scheme. 
 
3.5 Economic Analysis: Discussion 
 
It is widely perceived that the most cost-effective method of community fluoridation is via the 
water supply.
33,34,35
 Having made various assumptions about discounting rates and the size 
of the population to be served, Birch
25
 has produced estimated costs per dmft/DMFT year 
saved ranging from £1.60 to £27.02. To make a fair comparison with our analysis, the Birch 
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figures need to be inflated by 10 years. The Retail Prices Index (RPI) indicates an inflation 
rate of 40% for the period 1988 to 1998.
36
 Inflating the Birch figures to 1998 prices using the 
RPI implies a range of water fluoridation cost-effectiveness figures from £2.24 to £37.83. 
Even allowing for inflation, there are differences in discounting rate and population size 
assumptions and the Birch analysis ignores any potential savings from avoided treatment 
costs. Bearing these differences in mind, the cost-effectiveness ratios resulting from the two 
sets of analyses are broadly comparable and of similar magnitude. Dixon and Shackley
37
 
point out that because published papers on the economics of water fluoridation (including 
Birch) have not taken into account the economic welfare losses (e.g. utility losses and/or the 
costs of having to purchase fluoride filters) for those members of society opposed to water 
fluoridation, the health and economic benefits of such water fluoridation schemes have been 
over-estimated. Also, any non-caries health benefits of fluoridated milk have been explicitly 
excluded from the analysis presented in these guidelines, so that the overall benefits of milk 
fluoridation have been under-estimated. Allowing for all these factors, it seems reasonable 
to argue that milk fluoridation can be as cost-effective as water fluoridation under certain 
circumstances. This comparison is a relative one and it is important to point out that both the 
costs and the benefits to the community in absolute terms will be higher for water 
fluoridation schemes. 
 
The modelling presented in this paper has required a number of simplifying assumptions 
about key variables, including the number of years that children receive fluoridated milk, the 
number of days per year that the milk is administered, and the proportion of parents giving 
consent. Whilst affecting the absolute levels of costs and benefits, changes to the values in 
the above variables will have very little impact on the cost-effectiveness results presented 
because of the proportional effects on both the numerator and the denominator. 
 
An issue from the health authority’s point of view is to consider how much of the cost of a 
fluoridated milk scheme it is willing, or will have, to bear relative to the Local Authority and/or 
parents. In the schemes in the North-West of England, the only costs born by the NHS are 
the staff costs for the health authority and the community dental service. Thus, the most 
relevant cost and cost-effectiveness scenarios presented in this Guidance Note would be 
the health authority low cost scenarios. However, the high cost scenarios may be more 
relevant for health authorities in areas where Local Authorities and or parents are unable or 
unwilling to meet the costs of schemes. 
 
In order to help health authorities estimate their own cost and benefit scenarios a ready-
reckoner spreadsheet will be developed to supplement this Guidance Note. This will be 
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made available on the Working Group on Acute Purchasing (WGAP) web-site: 
(http://www.shef.ac.uk/uni/academic/R-Z/tiwgap/ ). 
 
The relative cost-effectiveness of a fluoridation scheme for a whole health district will 
depend on the differing proportions of the population at the various levels of risk of caries. 
Clearly, the most cost-effective strategy for a health authority to adopt would be to target the 
high caries areas initially, moving to lower caries areas at a later stage. However, because 
of equity considerations, such a policy may not be acceptable.  
 
The relative cost-effectiveness of methods of fluoridation is dependent upon disease levels 
and upon political, administrative, and technical influences. Water is likely to remain the first 
choice method of fluoridation where it is technically possible, economic, and politically 
acceptable to fluoridate water supplies. We have demonstrated that milk fluoridation is as 
cost-effective, if not more cost-effective than water fluoridation under many of the 
circumstances modelled, though the total benefits will clearly not be as great as from a 
water scheme. 
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4. OPTIONS FOR PURCHASERS AND PROVIDERS 
 
The following options are not necessarily mutually exclusive. 
 
Option 1:  Do nothing. The evidence from Doncaster and most other districts in Trent 
indicates that without any fluoride-based intervention
3
 it is extremely unlikely 
that the Government's target of a dmft of one for five year old children by the 
year 2003 will be achieved. This is, therefore, not a reasonable option. 
 
Option 2: In districts where universal water fluoridation may prove to be impractical for 
technical, political or other reasons, consider milk fluoridation as a long-term 
strategy to reduce dental caries in the infant and junior school children in 
those areas which may never benefit from water fluoridation. Factors, such 
as, a central milk supply, Local Authority support and a sufficiently high 
disease level for there to be a demonstrable benefit must be taken into 
account. Value for money for purchasers must be a strong feature of a milk 
fluoridation scheme. However, as shown above, the benefits may be acquired 
relatively cheaply. 
 
Option 3 In districts with a low level of dental caries, but with pockets of high disease, 
milk fluoridation may be considered as a cost-effective solution for those 
small areas. For example, Boston has a mean dental caries level in five year 
old children which is more than  twice that of the surrounding rural area in 
South Lincolnshire.
38
 Fluoridated milk in targeted areas could be a cost-
effective alternative to the fluoridation of the water supply to the whole of a 
sparsely-populated rural area, and its use could be considered as a long-term 
strategy. 
 
Option 4 Pursue water fluoridation in each district in the Trent Region. This option is 
the one most likely to enable all districts to achieve the Government's target, 
but not by 2003. However, despite the passing of the Water Fluoridation Act 
in 1985, there have been no new water fluoridation schemes since then. A 
flaw in the current legislation gives a veto on all water fluoridation schemes to 
the water authorities who exercise this veto. Yorkshire Water Authority in 
particular is implacably opposed to the introduction of it in their water supply 
until the Government makes it mandatory. The Government's policy on this is 
not yet formulated despite recommendations from the Acheson Report.
39
 
Even if the Act is amended in 1999, it may still take an average of five years 
 28 
before any new schemes are operating. The benefit would certainly not then 
be demonstrated by 2003. Thus, this remains the long-term strategy of 
choice. 
 
Option 5 In districts where universal water fluoridation may be possible, consider 
fluoridated milk as a short-term strategy until water fluoridation is achieved. 
The benefits of fluoride would be provided directly to the most vulnerable age 
groups, but there is still no real possibility of the Government's target for five 
year olds being achieved by 2003. The scheme would then subsequently be 
made redundant if water fluoridation was introduced for the benefit of the 
whole population. 
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5. DISCUSSION AND CONCLUSIONS 
 
Dental caries is a universal disease of the industrial age. Whilst it is not usually fatal (except 
for the persistent number of deaths each year of young children under general anaesthesia 
for extractions), it is a disease causing pain, infection, misery and possible disfigurement for 
any member of society, but particularly children. It is almost entirely preventable by dietary 
control of non-milk extrinsic sugars
40
, and the introduction into the water supply of fluoride at 
one ppm.
41
 However, epidemiological studies of a rigorous nature in the Trent Region show 
that the level of dental caries remains at an unacceptable level in most districts in the region. 
Indeed, the variation in disease experience within each district may be greater than the 
whole range of averages between districts, as shown for Doncaster as an example. The 
Government's target of an average dmft of one for five year old children may not be 
achieved by 2003 without community programmes delivering fluoride at an efficacious level 
in most districts. This report has examined one of those community programmes for 
possible use in the Trent Region. The conclusions drawn from the study are as follows:- 
 
a) Fluoride as part of a community programme is the only reliable method available to 
health authorities to achieve the Government's target for the reduction of dental 
caries in five year olds by the year 2003. 
 
b) Fluoridated water at one ppm remains the most effective way of reducing dental 
caries in the whole population. However, little progress has been made in the UK as 
a whole, and the Trent Region in particular, in extending this since 1985. 
 
c) Fluoridated milk can be a relatively cost-effective and practical way to prevent dental 
decay in the populations which consume it. Whilst it does not provide lifetime cover 
as water fluoridation does, nor the overall level of caries reduction, it does reduce 
decay in a crucial period of development of the mouth, at an age when operative 
dental care is not easy to provide or be tolerated. If started at age four, it may enable 
some districts in the Trent Region to achieve the Government's target for caries 
reduction in five year olds by 2003. 
 
d) Fluoridating milk has the advantage that it does not require widespread consultation 
with the public, as consent is required only from the parents of the children who 
receive it. This is a factor in why fluoridated milk schemes can be introduced 
relatively quickly compared with water schemes. Consequently, milk fluoridation may 
be considered as a forerunner to fluoridation of water during the years taken to set 
up a water scheme. 
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e) Fluoridated milk may be a cost-effective way of preventing dental caries in younger 
children on a permanent basis where water fluoridation remains impractical or 
impossible. Whilst it may never achieve the caries-reduction of water fluoridation, 
nevertheless it remains a proven preventative measure for those who consume it. 
 
f) Districts in the Trent Region should examine their individual circumstances, using the 
previously-described methodology, to assess the benefits of milk fluoridation for 
target groups of their population, and consider introducing it as soon as possible.  
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 Coleman, J Radford, JA Tidy. 
£10.00 
    
Discussion Papers  
  
No. 1. Patients with Minor Injuries: A Literature Review of Options for their    £7.00 
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